Research
Search
Genes / Clones
Expression
Mutants / Tg
Antibodies
Anatomy / GO / Human Disease / Chemical
Publications
Data Mining
Downloads
Data Model
AllianceMine
BioMart
Genomics
BLAST
ZFIN
Ensembl
NCBI
UCSC
Genome Browsers
ZFIN
Ensembl
Vega
GRC
UCSC
NCBI
Resources
Zebrafish Genomics
Other Genome Databases
Resources
General
The Zebrafish Book
Protocol Wiki
Antibody Wiki
Anatomy Atlases
Resources for Students and Educators
Zebrafish Programs
ZF-Health
Husbandry Resources
More...
Resource Centers
Zebrafish International Resource Center (ZIRC)
China Zebrafish Resource Center (CZRC)
European Zebrafish Resource Center (EZRC)
Community
Announcements
News
Meetings
Jobs
Alliance Community Forum
Search
People
Labs
Companies
Societies
International Zebrafish Society (IZFS)
Zebrafish Disease Models Society (ZDMS)
Genetics Society of America (GSA)
Zebrafish Husbandry Association
Support
Nomenclature
Nomenclature Conventions
Line Designations
Wild-Type Lines
Submit a Proposed Gene Name
Submit a Proposed Mutant/Tg Line Name
Publications
Guidelines for Authors
Zebrashare
Citing ZFIN
Using ZFIN
Help & Tips
Glossary
Single Box Search Help
Submit Data
Terms of Use
About Us
About ZFIN
Contact Information
Statistics
Committees
Jobs at ZFIN
Sign In
Phenotype Figure Summary
Marker:
elovl2
Conditions:
Standard or Control
Publication
Data
Fish
Anatomy
Dasyani
et al.
, 2020
Figure 2
AB + CRISPR3-elovl2 + CRISPR4-elovl2
eye very long-chain fatty acid biosynthetic process decreased occurrence, abnormal
whole organism very long-chain fatty acid biosynthetic process decreased occurrence, abnormal
Figure 3
AB + CRISPR3-elovl2 + CRISPR4-elovl2
retina increased thickness, abnormal
Figure 5
AB + CRISPR3-elovl2 + CRISPR4-elovl2
response to absence of light decreased magnitude, abnormal
response to light stimulus magnitude, abnormal
Liu
et al.
, 2020
Fig. 1
elovl2
ihb332/ihb332
(AB)
liver
elovl2
expression absent, abnormal
Fig. 2
elovl2
ihb332/ihb332
(AB)
liver
elovl2
expression decreased amount, abnormal
liver
elovl5
expression increased amount, abnormal
liver
fads2
expression increased amount, abnormal
liver docosahexaenoic acid decreased amount, abnormal
liver icosapentaenoic acid increased amount, abnormal
Sun
et al.
, 2020
Fig. 1
elovl2
zf3426/zf3426
liver alpha-linolenic acid increased amount, abnormal
liver docosahexaenoic acid decreased amount, abnormal
liver icosapentaenoate increased amount, abnormal
muscle alpha-linolenic acid increased amount, abnormal
muscle docosahexaenoic acid decreased amount, abnormal
muscle docosapentaenoate decreased amount, abnormal
muscle icosapentaenoate increased amount, abnormal
Fig. 2
elovl2
zf3426/zf3426
liver lysophosphatidylcholine increased amount, abnormal
liver lysophosphatidylethanolamine increased amount, abnormal
liver phosphatidylcholine increased amount, abnormal
liver phosphatidylethanolamine increased amount, abnormal
Fig. 3
elovl2
zf3426/zf3426
liver
elovl2
expression decreased amount, abnormal
liver
elovl4a
expression increased amount, abnormal
liver
elovl5
expression decreased amount, abnormal
Your Input Welcome
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Name:
Institution:
Email address:
Please leave blank:
Subject:
Comments:
Send your comments
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.